News

FDA Issues Highest Risk Warning For Dubai Chocolate Recall
The Food and Drug Administration has updated their recall of a batch of Dubai chocolate spread to Class I, their highest ...
FDA makes Juul’s reign official
The FDA authorized Juul’s applications on Thursday to sell e-cigarettes in the U.S., determining they’re “appropriate for the ...
FDA Approves Juul E-Cigs for Sale, Years After Ban Attempt
FRIDAY, July 18, 2025 (HealthDay News) — After years of legal battles and health concerns, Juul Labs has the go-ahead to sell ...
FDA Issues Risk Warning for Ice Cream Recalled in 23 States
Rich Ice Cream Co. recalled numerous lots of its products on June 27 over potential contamination with Listeria monocytogenes ...
FDA recalls over 67,000 cases of Power Stick deodorant. See where products were sold
The manufacturer announced a recall of 67,214 cases of its Power Stick roll-on deodorant due to violations of Current Good ...
Juul gets FDA’s OK to keep selling tobacco and menthol e-cigarettes
The Food and Drug Administration is allowing vaping brand Juul to keep its e-cigarettes on the market, providing relief to a ...
FDA Plans to Revoke 52 Food Standards
The 52 food standards pertain to canned fruits and vegetables, dairy products, baked goods, macaroni products, and other ...
GSK Shares Drop After FDA Committee Vote Leaves Cancer-Drug Comeback in Doubt
The pharmaceutical company said it remained confident in the benefit and risk profile of Blenrep and will continue to work ...
FDA panel reassesses hormone therapy warnings in menopause treatments
The Food and Drug Administration is reassessing some warnings given about hormone therapy treatments for menopause that have ...
MedPage Today20h
FDA Reviewers Flag Inconsistent Data for Rexulti in PTSD
The CAPS-5 total score ranks severity of 20 PTSD symptoms from 0 (not present) to 80 (most severe). Baseline values for the ...
FDA Authorizes Juul’s E-Cigarettes After Ban Nearly Bankrupted Firm
The regulator authorized the company to keep its e-cigarettes on the U.S. market after a federal ban in 2022 had pushed it to ...
STAT8h
FDA advisers say risks of GSK blood cancer drug outweigh benefits in surprise setback
FDA advisers on Thursday voted against GSK's blood cancer drug Blenrep, finding that its risks outweighed its benefits at the ...